GALECTIN THERAPEUTICS INC (GALT) Stock Cash Flow
NASDAQ:GALT - Nasdaq - US3632252025 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -45.08M | -41.07M | -38.78M | -30.53M | -23.47M | |||
| Depreciation Amortization | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 6.90M | 4.68M | 4.97M | 3.75M | 940.00K | |||
| Other non cash items | 4.51M | 3.42M | 2.75M | 2.47M | 1.92M | |||
| OPERATING CASH FLOW | -33.68M | -32.97M | -31.06M | -24.31M | -20.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| Other Investing Activity | N/A | 0.00 | 0.00 | 0.00 | N/A | |||
| INVESTING CASH FLOW | N/A | 0.00 | 0.00 | 0.00 | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 40.00M | 30.00M | 10.00M | 30.00M | N/A | |||
| Stock Issued/Repurchased | N/A | 10.03M | 0.00 | 6.81M | 260.00K | |||
| Dividend Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 40.38M | 40.03M | 10.00M | 36.81M | 260.00K | |||
| CHANGE IN CASH | 6.70M | 7.07M | -21.06M | 12.50M | -20.34M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -33.68M | -32.97M | -31.06M | -24.31M | -20.60M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -33.68M | -32.97M | -31.06M | -24.31M | -20.60M | |||
All data in USD